Zacks Research Has Bearish Estimate for Exelixis Q1 Earnings
Exelixis, Inc. (NASDAQ:EXEL – Free Report) – Research analysts at Zacks Research dropped their Q1 2025 EPS estimates for Exelixis in a research report issued on Monday, March 3rd. Zacks Research analyst E. Bagri now forecasts that the biotechnology company will post earnings per share of $0.35 for the quarter, down from their prior forecast […]
Exelixis, Inc. (NASDAQ:EXEL – Free Report) – Research analysts at Zacks Research dropped their Q1 2025 EPS estimates for Exelixis in a research report issued on Monday, March 3rd. Zacks Research analyst E. Bagri now forecasts that the biotechnology company will post earnings per share of $0.35 for the quarter, down from their prior forecast […]
